1. Home
  2. NXDT vs STIM Comparison

NXDT vs STIM Comparison

Compare NXDT & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXDT
  • STIM
  • Stock Information
  • Founded
  • NXDT 2012
  • STIM 2003
  • Country
  • NXDT United States
  • STIM United States
  • Employees
  • NXDT N/A
  • STIM N/A
  • Industry
  • NXDT Investment Managers
  • STIM Medical/Dental Instruments
  • Sector
  • NXDT Finance
  • STIM Health Care
  • Exchange
  • NXDT Nasdaq
  • STIM Nasdaq
  • Market Cap
  • NXDT 223.1M
  • STIM 221.8M
  • IPO Year
  • NXDT N/A
  • STIM 2018
  • Fundamental
  • Price
  • NXDT $4.00
  • STIM $3.34
  • Analyst Decision
  • NXDT
  • STIM Buy
  • Analyst Count
  • NXDT 0
  • STIM 4
  • Target Price
  • NXDT N/A
  • STIM $5.67
  • AVG Volume (30 Days)
  • NXDT 133.6K
  • STIM 1.3M
  • Earning Date
  • NXDT 01-01-0001
  • STIM 08-05-2025
  • Dividend Yield
  • NXDT 9.66%
  • STIM N/A
  • EPS Growth
  • NXDT N/A
  • STIM N/A
  • EPS
  • NXDT 0.99
  • STIM N/A
  • Revenue
  • NXDT N/A
  • STIM $111,106,000.00
  • Revenue This Year
  • NXDT N/A
  • STIM $105.22
  • Revenue Next Year
  • NXDT N/A
  • STIM $11.89
  • P/E Ratio
  • NXDT $6.41
  • STIM N/A
  • Revenue Growth
  • NXDT N/A
  • STIM 54.17
  • 52 Week Low
  • NXDT $5.89
  • STIM $0.52
  • 52 Week High
  • NXDT $13.07
  • STIM $5.92
  • Technical
  • Relative Strength Index (RSI)
  • NXDT 37.09
  • STIM 32.24
  • Support Level
  • NXDT $3.86
  • STIM $3.79
  • Resistance Level
  • NXDT $4.69
  • STIM $4.85
  • Average True Range (ATR)
  • NXDT 0.32
  • STIM 0.39
  • MACD
  • NXDT -0.08
  • STIM -0.13
  • Stochastic Oscillator
  • NXDT 38.71
  • STIM 0.33

About NXDT NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: